Literature DB >> 19687250

Regional dissemination of KPC-producing Klebsiella pneumoniae.

Brandon Kitchel1, Daniel R Sundin, Jean B Patel.   

Abstract

Production of a Klebsiella pneumoniae carbapenemase (KPC) is the most common mechanism of carbapenem resistance in the United States; however, until now, KPC-producing isolates have not been found in western Michigan. Molecular typing of two KPC-producing K. pneumoniae isolates from Michigan showed their similarity to other Midwestern isolates. They were also unrelated to the dominant sequence type observed throughout the United States, multilocus sequence type 258. This could represent regional dissemination of another KPC-producing K. pneumoniae strain.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19687250      PMCID: PMC2764151          DOI: 10.1128/AAC.00784-09

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  15 in total

1.  Plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC in a Klebsiella pneumoniae isolate from France.

Authors:  Thierry Naas; Patrice Nordmann; Gérard Vedel; Claire Poyart
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

2.  Interpretation of pulsed-field gel electrophoresis patterns in foodborne disease investigations and surveillance.

Authors:  Timothy J Barrett; Peter Gerner-Smidt; Bala Swaminathan
Journal:  Foodborne Pathog Dis       Date:  2006       Impact factor: 3.171

3.  First identification of Pseudomonas aeruginosa isolates producing a KPC-type carbapenem-hydrolyzing beta-lactamase.

Authors:  Maria Virginia Villegas; Karen Lolans; Adriana Correa; Juan Nicolas Kattan; Jaime A Lopez; John P Quinn
Journal:  Antimicrob Agents Chemother       Date:  2007-01-29       Impact factor: 5.191

4.  Multilocus sequence typing of Klebsiella pneumoniae nosocomial isolates.

Authors:  Laure Diancourt; Virginie Passet; Jan Verhoef; Patrick A D Grimont; Sylvain Brisse
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

5.  Evolution of antimicrobial resistance among Pseudomonas aeruginosa, Acinetobacter baumannii and Klebsiella pneumoniae in Brooklyn, NY.

Authors:  David Landman; Simona Bratu; Sandeep Kochar; Monica Panwar; Manoj Trehan; Mehmet Doymaz; John Quale
Journal:  J Antimicrob Chemother       Date:  2007-05-09       Impact factor: 5.790

6.  Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 beta-lactamases in New York City.

Authors:  Patricia A Bradford; Simona Bratu; Carl Urban; Melissa Visalli; Noriel Mariano; David Landman; James J Rahal; Steven Brooks; Sanda Cebular; John Quale
Journal:  Clin Infect Dis       Date:  2004-06-14       Impact factor: 9.079

Review 7.  Class A carbapenemases.

Authors:  Jan Walther-Rasmussen; Niels Høiby
Journal:  J Antimicrob Chemother       Date:  2007-06-26       Impact factor: 5.790

8.  Emergence of Serratia marcescens, Klebsiella pneumoniae, and Escherichia coli Isolates possessing the plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in intensive care units of a Chinese hospital.

Authors:  Jia Chang Cai; Hong Wei Zhou; Rong Zhang; Gong-Xiang Chen
Journal:  Antimicrob Agents Chemother       Date:  2008-03-10       Impact factor: 5.191

9.  Molecular epidemiology of KPC-producing Klebsiella pneumoniae isolates in the United States: clonal expansion of multilocus sequence type 258.

Authors:  Brandon Kitchel; J Kamile Rasheed; Jean B Patel; Arjun Srinivasan; Shiri Navon-Venezia; Yehuda Carmeli; Alma Brolund; Christian G Giske
Journal:  Antimicrob Agents Chemother       Date:  2009-06-08       Impact factor: 5.191

10.  Genetic structures at the origin of acquisition of the beta-lactamase bla KPC gene.

Authors:  Thierry Naas; Gaelle Cuzon; Maria-Virginia Villegas; Marie-Frédérique Lartigue; John P Quinn; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2008-01-28       Impact factor: 5.191

View more
  16 in total

1.  Population Structure of Klebsiella pneumoniae Causing Bloodstream Infections at a New York City Tertiary Care Hospital: Diversification of Multidrug-Resistant Isolates.

Authors:  Angela Gomez-Simmonds; Michelle Greenman; Sean B Sullivan; Joshua P Tanner; Madeleine G Sowash; Susan Whittier; Anne-Catrin Uhlemann
Journal:  J Clin Microbiol       Date:  2015-04-15       Impact factor: 5.948

Review 2.  Leveraging antimicrobial stewardship into improving rates of carbapenem-resistant Enterobacteriaceae.

Authors:  Darren Wong; Brad Spellberg
Journal:  Virulence       Date:  2016-05-17       Impact factor: 5.882

Review 3.  Pharmacodynamic and pharmacokinetic considerations in the treatment of critically Ill patients infected with carbapenem-resistant Enterobacteriaceae.

Authors:  Elizabeth A Neuner; Jason C Gallagher
Journal:  Virulence       Date:  2016-08-09       Impact factor: 5.882

Review 4.  The Epidemiology, Evolution, and Treatment of KPC-Producing Organisms.

Authors:  Ann Marie Porreca; Kaede V Sullivan; Jason C Gallagher
Journal:  Curr Infect Dis Rep       Date:  2018-05-05       Impact factor: 3.725

Review 5.  Carbapenem resistance: overview of the problem and future perspectives.

Authors:  Georgios Meletis
Journal:  Ther Adv Infect Dis       Date:  2016-02

6.  IMP-producing carbapenem-resistant Klebsiella pneumoniae in the United States.

Authors:  Brandi M Limbago; J Kamile Rasheed; Karen F Anderson; Wenming Zhu; Brandon Kitchel; Nancy Watz; Susan Munro; Hayley Gans; Niaz Banaei; Alex J Kallen
Journal:  J Clin Microbiol       Date:  2011-10-12       Impact factor: 5.948

7.  Increase of ceftazidime- and fluoroquinolone-resistant Klebsiella pneumoniae and imipenem-resistant Acinetobacter spp. in Korea: analysis of KONSAR study data from 2005 and 2007.

Authors:  Kyungwon Lee; Mi Ae Lee; Chae Hoon Lee; Jongwook Lee; Kyoung Ho Roh; Sunjoo Kim; Jin Ju Kim; Eunmi Koh; Dongeun Yong; Yunsop Chong
Journal:  Yonsei Med J       Date:  2010-11       Impact factor: 2.759

8.  Dramatic increase of third-generation cephalosporin-resistant E. coli in German intensive care units: secular trends in antibiotic drug use and bacterial resistance, 2001 to 2008.

Authors:  Elisabeth Meyer; Frank Schwab; Barbara Schroeren-Boersch; Petra Gastmeier
Journal:  Crit Care       Date:  2010-06-14       Impact factor: 9.097

Review 9.  Role of newer and re-emerging older agents in the treatment of infections caused by carbapenem-resistant Enterobacteriaceae.

Authors:  Joshua T Thaden; Jason M Pogue; Keith S Kaye
Journal:  Virulence       Date:  2016-07-06       Impact factor: 5.882

10.  Klebsiella pneumoniae antimicrobial drug resistance, United States, 1998-2010.

Authors:  Guillermo V Sanchez; Ronald N Master; Richard B Clark; Madiha Fyyaz; Padmaraj Duvvuri; Gupta Ekta; Jose Bordon
Journal:  Emerg Infect Dis       Date:  2013-01       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.